Anonymous ID: 387ff3 Feb. 22, 2023, 1:51 a.m. No.18393144   🗄️.is 🔗kun   >>3147 >>3149 >>3214 >>3246 >>3263

Boo Pete BUTT-PLUG right out of Ohio!

 

Well, we’ll. Pothole Pete going to East Palestine tomorrow hoping to overshadow Trump’s visit 🤣🤣

 

I hope he gets his puny little ass booed out of town.

 

 

https://twitter.com/atensnut/status/16282546602754457

Anonymous ID: 387ff3 Feb. 22, 2023, 1:53 a.m. No.18393147   🗄️.is 🔗kun   >>3149

>>18393144

CDC Updates Profile For Vinyl Chloride Days Before Ohio Train Derailment, And Removes Section On How It Affects Children

 

Why did the CDC update its page for vinyl chloride nearly two weeks before the Ohio train derailment? The CDC edited its profile for vinyl chloride just recently, removing a section on how the chemical affects children.

 

On February 3, a Norfolk Southern Railroad train derailed in East Palestine, Ohio, emitting toxic clouds into the air and water supplies. Officials issued an emergency evacuation shortly after, but residents have since returned home. The catastrophe has been downplayed by the media, and the Environmental Protection Agency has deemed the water "safe to drink" – despite the existing reports of wildlife dying in the affected area.

 

Now it seems even the CDC is minimizing the effects of the chemicals involved in the crash, one of them being vinyl chloride, a gas used to produce a plastic known as polyvinyl chloride (PVC). According to the National Cancer Institute, vinyl chloride is a carcinogen that has links to different kinds of cancers, including liver, brain, and lung cancers, as well as lymphoma and leukemia.

 

In January 2023, the toxicological profile for vinyl chloride was revised from the original guidelines published in the Federal Register nearly four decades ago – on April 17, 1987, to be exact. While toxicological profiles are updated occasionally, users are alarmed by the odd timing. The last profile for vinyl chloride was released in 2006, 17 years ago. It's strange that they drafted it again in January 2023, just weeks prior to the catastrophe in East Palestine.

 

The CDC's website page for vinyl chloride was recently modified as well. An archived version displays a longer, more detailed FAQ page before the changes were made. The screenshot below shows a long list of FAQs with additional information. The profile initially had the following sections: "How can vinyl chloride affect children?" and "Has the federal government made recommendations to protect human health?" – but both have since been removed.

 

https://www.eviemagazine.com/post/cdc-updates-profile-vinyl-chloride-before-ohio-train-derailment

Anonymous ID: 387ff3 Feb. 22, 2023, 1:56 a.m. No.18393156   🗄️.is 🔗kun   >>3168 >>3214 >>3246

Wake-up Call: BlackRock and Vanguard Are Nearly in TOTAL CONTROL of Food Production and Distribution in America

 

Some of the major players who have been behind the scenes in the recent past are quickly taking very public control over our future. It's time to stand up and point a spotlight on them.

 

https://noqreport.com/2022/05/02/wake-up-call-blackrock-and-vanguard-are-nearly-in-total-control-of-food-production-and-distribution-in-america/

 

In control over our food production and distribution!

 

BlackRock & Vanguard are Taking Over US Centralized Food Production to Control Food Supply

 

https://www.newstreason.com/post/blackrock-vanguard-are-taking-over-us-centralized-food-production-to-control-food-supply

Anonymous ID: 387ff3 Feb. 22, 2023, 2:18 a.m. No.18393220   🗄️.is 🔗kun   >>3246

>>18393210

>>18393198

>>18393187

 

https://www.pdsoros.org/news-events/2017-04-03-pursuing-the-potential-of-abandoned-pharmaceuticals

 

Pursuing the Potential of Abandoned Pharmaceuticals

 

 

When Pavan Cheruvu sent Vivek Ramaswamy an email out of the blue in the fall of 2015, he did so because he wanted to work with Vivek, a fellow Paul & Daisy Soros alumnus and the founder of Roivant Sciences, a biopharmaceutical company that aims to accelerate the development of new medicines.

 

But he wasn’t applying for a job. He was proposing one.

 

“I realize this is unconventional but I obtained your email from the PD Soros alumni site and I'm reaching out because I've been following your progress over the last year,” wrote Pavan, a 2004 Fellow, on Tuesday, Sept. 15, a few months after Roivant subsidiary Axovant Sciences, which focuses on Alzheimer’s disease and other forms of dementia, had a record-breaking IPO. “In brief, I would like to work with you.”

 

Pavan, who was working as a fellow in cardiovascular medicine at the time, went on to suggest that he fill a position that did not exist at Roivant—chief of staff. After he sent the email, he told his wife he didn’t expect to hear back. But he did. The same day.

 

The Paul & Daisy Soros Fellowships for New Americans supported Vivek at Yale Law School. He graduated in 2013.

 

After Pavan’s email, the pair connected over the phone on a Saturday at 6:30 a.m. ET, the slot Vivek offered not realizing Pavan lived in San Francisco, where it was only 3:30.

 

“He sounded fresh as top of the morning,” Vivek said.

 

Founded in 2014, Roivant—the “Roi” stands for “return on investment”—is parent to a family of subsidiaries that staff members lovingly call “vants.” The companies are focused on rescuing drugs from what Vivek and Pavan describe as the “traffic jam” of the pharmaceutical industry. Roivant invests in drugs that show promise but have, for whatever reason, been abandoned by others, partnering with pharmaceutical companies or universities to complete the development or clinical trial process.

 

Each “vant” centers on a different therapeutic area. In addition to Axovant, there are Myovant (women’s health and prostate cancer), Enzyvant (rare diseases), and Dermavant (dermatologic conditions). Although none of the companies has a commercial product yet, they are getting close. Enzyvant anticipates a biologic license application in 2018 for a therapy for complete DiGeorge syndrome, a genetic disease; Axovant is completing a Phase 3 clinical study this year on the efficacy of intepirdine (also known as RVT-101) on patients with mild-to-moderate Alzheimer’s.

 

Vivek’s focus on Alzheimer’s was part of what attracted Pavan to his orbit. Therapies for the disease have eluded researchers for years. Lawrence T. Friedhoff, Roivant’s chief of research and development, helped create one of the leading Alzheimer’s drugs, Aricept, when he was at the pharmaceutical company Eisai. It was approved by the FDA in 1996.

Anonymous ID: 387ff3 Feb. 22, 2023, 2:55 a.m. No.18393289   🗄️.is 🔗kun   >>3291 >>3298

The US is Providing Ukraine a Long-range GPS-guided Bomb

 

The US is providing Ukraine a long-range GPS-guided bomb made by Boeing Co. that’s capable of hitting targets 45 miles away, industry officials said, Report informs referring to Bloomberg.

 

The Pentagon hasn’t formally acknowledged it’s sending the modified version of Boeing’s Joint Direct Attack Munition, saying only it would send “precision aerial munitions” as part of a $1.85 billion package announced December 21. But two people familiar with the matter confirmed the weapon is the Extended-Range Jdam, known as the Jdam-ER. They asked not to be identified because the detail hasn’t been announced.

 

Pentagon spokeswoman Kelly Flynn said US won’t identify the munition, citing operational security. Jdam kits are used by the Air Force and US Navy and have been sold to over 26 countries.

 

The Jdam-ER can be bolted on unguided bombs ranging from 500 pounds to 2,000 pounds. Once dropped, the bomb deploys wings, allowing it to glide up to 45 miles and tripling the range of the original weapon. The Extended-Range Jdam was developed in cooperation with the Royal Australian Air Force.

 

Boeing on January 20 received a $40.5 million order from the Air Force under an existing Jdam contract. The job calls for completion by June 30. The award indicates the US and Ukraine have cobbled together a method by which Soviet-era fighter jets flown by Ukraine can program and launch the Jdam-ER.

https://report.az/en/other-countries/us-to-provide-ukraine-with-jdam-er-long-range-version-of-gps-guided-bomb/

 

14 hours ago — The US is providing Ukraine a long-range GPS-guided bomb made by Boeing that's capable of hitting targets 45 miles away.

 

@GeneralMCNews